On December 16, 2021, the Board of Directors of Kala Pharmaceuticals, Inc. appointed Todd Bazemore, the Company’s Chief Operating Officer, to serve as the Company’s President and Chief Operating Officer, effective immediately. Mark Iwicki will continue to lead the Company as its Chief Executive Officer and as Chairman of the Board of Directors but will no longer serve as President of the Company. Mr. Bazemore has served as Chief Operating Officer of the Company since November 2017. Previously, he served as Executive Vice President and Chief Operating Officer of Santhera Pharmaceuticals (USA) Inc. from September 2016 until November 2017.